帕金森病患者的血脂水平及其相关性

doi:10.3969/j.issn.1006-9771.2019.03.019

《中国康复理论与实践》 ›› 2019, Vol. 25 ›› Issue (3): 352-356.doi: 10.3969/j.issn.1006-9771.2019.03.019

帕金森病患者的血脂水平及其相关性

于鸿远, 何景华, 刘双, 孙丽娟, 殷雁

大连医科大学附属第二医院神经内科，辽宁大连市 116027

收稿日期:2018-12-06 修回日期:2019-01-21 出版日期:2019-03-25 发布日期:2019-04-02
通讯作者: 殷雁,E-mail： 48907583@qq.com
作者简介:于鸿远(1992-)，女，汉族，吉林通化市人，硕士研究生，主要研究方向：帕金森病。
基金资助:
1.国家自然科学基金青年基金项目(No. 81801173)；2.辽宁省自然科学基金面上项目(No. 20180550891)

Relationship between Serum Lipid Levels and Parkinson's Disease

YU Hong-yuan, HE Jing-hua, LIU Shuang, SUN Li-juan, YIN Yan

Neurology Department, the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, China

Received:2018-12-06 Revised:2019-01-21 Published:2019-03-25 Online:2019-04-02
Contact: YIN Yan, E-mail： 48907583@qq.com
Supported by:
National Natural Science Foundation of China (Youth) (No. 81801173) and Liaoning Natural Science Foundation (General) (No. 20180550891)

摘要/Abstract

摘要： 目的探究血脂与帕金森病的关系以及对帕金森病的预测价值。方法 2016年1月至2018年11月，帕金森病患者145例为患者组，同期122例健康体检者为对照组，检测血脂水平，分析各项血脂指标与帕金森病病程、疾病严重程度和运动分型的相关性，计算相关血脂指标的预测值。结果患者组总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A1 (ApoA1)、载脂蛋白B (ApoB)均低于对照组(t > 2.089, P < 0.05)；Logistic回归分析显示，ApoA1是患帕金森病的保护因素(OR = 0.081, P < 0.01)。ApoA1的最佳截取阈值为1.38 mmol/L，敏感度性0.72，特异性0.68。结论帕金森病患者总体血脂水平低于健康人，低ApoA1可能是帕金森病发病的潜在独立危险因素，可以作为预测帕金森病患病风险的参考。

关键词: 帕金森病, 血脂, 载脂蛋白A1, 相关性

Abstract: Objective To investigate the relationship between serum lipids and Parkinson's disease, and its predictive value for Parkinson's disease. Methods From January, 2016 to November, 2018, 145 patients with Parkinson's disease and other 122 healthy subjects were selected. They were measured the various lipid indexes. Results Total cholesterol, low density lipoprotein cholesterol, Apolipoprotein A1 (ApoA1) and Apolipoprotein B (ApoB) were less in the patients than in the controls (t > 2.089, P < 0.05). ApoA1 was an independent protective factor from Logistic regression (OR = 0.081, P < 0.01). The most optimal cut-off threshold of ApoA1 was 1.38 mmol/L, with the sensitivity of 0.72 and the specificity of 0.68. Conclusion The lipid decreased in patients with Parkinson's disease. Low ApoA1 may be a potential independent risk factor for Parkinson's disease, which may be a predictor for it.

Key words: Parkinson's disease, serum lipids, apolipoprotein A1, correlation

中图分类号:

R742.5

于鸿远, 何景华, 刘双, 孙丽娟, 殷雁. 帕金森病患者的血脂水平及其相关性[J]. 《中国康复理论与实践》, 2019, 25(3): 352-356.

YU Hong-yuan, HE Jing-hua, LIU Shuang, SUN Li-juan, YIN Yan. Relationship between Serum Lipid Levels and Parkinson's Disease[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2019, 25(3): 352-356.

参考文献

1 ZhangT, YuS, GuoP, et al. Nonmotor symptoms in patients with Parkinson disease: a cross-sectional observational study [J]. Medicine, 2016, 95(50): e5400.
2 黄星会,霍丽涛,吴庆文,等. 帕金森病的非运动症状及研究进展[J]. 中国康复理论与实践, 2013, 19(11): 1013-1015.
3 王刚,崔海伦,刘军,等. 帕金森病发病机制及诊断与治疗转化研究进展[J]. 中国现代神经疾病杂志, 2018, 18(1): 19-24.
4 RizekP, KumarN, JogMS. An update on the diagnosis and treatment of Parkinson disease [J]. CMAJ, 2016, 188(16): 1157-1165.
5 HuangX, AbbottR D, PetrovitchH, et al. Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study [J]. Mov Disord, 2010, 23(7): 1013-1018.
6 SimonK C, ChenH, SchwarzschildM, et al. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease [J]. Neurology, 2007, 69(17): 1688-1695.
7 de LauL M, KoudstaalP J, HofmanA, et al. Serum cholesterol levels and the risk of Parkinson's disease [J]. Am J Epidemiol, 2006, 164(10): 998-1002.
8 GuoX, SongW, ChenK, et al. The serum lipid profile of Parkinson's disease patients: a study from China [J]. Int J Neurosci, 2015, 125(11): 838-844.
9 EmamzadehF N, SurguchovA. Parkinson's disease: biomarkers, treatment, and risk factors [J]. Front Neurosci, 2018, 12: 612.
10 PaulR, ChoudhuryA, KumarS, et al. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: involvement of mitochondrial dysfunctions and oxidative stress [J]. PLoS One, 2017, 12(2): e0171285.
11 中华医学会神经病学分会帕金森病及运动障碍学组. 中国帕金森病的诊断标准(2016版)[J]. 中华神经科杂志, 2016, 49(4): 268-271.
12 SchragA, JahanshahiM, QuinnN. What contributes to quality of life in patients with Parkinson's disease? [J]. J Neurol Neurosurg Psychiatry, 2000, 69(3): 308-312.
13 HoehnM M, YahrM D. Parkinsonism: onset, progression and mortality [J]. Neurology, 2001, 57(3): 11-26.
14 VanceJ E. Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases [J]. Dis Model Mech, 2012, 5(6): 746-755.
15 LiL, LiuM S, LiG Q, et al. Relationship between apolipoprotein superfamily and Parkinson's disease [J]. Chin Med J (Engl), 2017, 130(21): 2616-2623.
16 QiangJ K, WongY C, SiderowfA, et al. Plasma apolipoprotein A1 as a biomarker for Parkinson disease [J]. Ann Neurol, 2013, 74(1): 119-127.
17 WangE S, SunY, GuoJ G, et al. Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson's disease [J]. Acta Neurol Scand, 2010, 122(5): 350-359.
18 GaoX, SimonK C, SchwarzschildM A, et al. Prospective study of statin use and risk of Parkinson disease [J]. Arch Neurol, 2012, 69(3): 380-384.
19 LeeY C, LinC H, WuR M, et al. Discontinuation of statin therapy associates with Parkinson disease: a population-based study [J]. Neurology, 2013, 81(5): 410-416.
20 SwansonC R, LiK, UngerT L, et al. Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype [J]. Mov Disord, 2015, 30(6): 805-812.
21 LewisT L, CaoD, LuH, et al. Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease [J]. J Biol Chem, 2010, 285(47): 36958-36968.
22 ArenasF, Garcia-RuizC, Fernandez-ChecaJ C. Intracellular cholesterol trafficking and impact in neurodegeneration [J]. Front Mol Neurosci, 2017, 10: 382.
23 LimL, Jackson-LewisV, WongL C, et al. Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease [J]. Cell Death Differ, 2012, 19(3): 416-427.
24 HuangX, AuingerP, EberlyS, et al. Serum cholesterol and the progression of Parkinson's disease: results from DATATOP [J]. PLoS One, 2011, 6(8): e22854.
25 BennM, NordestgaardB G, Frikke-SchmidtR, et al. Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study [J]. BMJ, 2017, 357: j1648.
26 LuoL, YuanX, HuangW, et al. Safety of coadministration of ezetimibe and statins in patients with hypercholesterolaemia: a meta-analysis [J]. Intern Med J, 2015, 45(5): 546-557.
27 ZhangL, WangX, WangM, et al. Circulating cholesterol levels may link to the factors influencing Parkinson's risk [J]. Front Neurol, 2017, 8: 501.
28 van der MarkM, NijssenP C, VlaanderenJ, et al. A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking [J]. PLoS One, 2014, 9(4): e95297.
29 ChenH, HuangX, GuoX, et al. Smoking duration, intensity, and risk of Parkinson disease [J]. Neurology, 2010, 74(11): 878-884.
30 RitzB, LeeP C, LassenC F, et al. Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease [J]. Neurology, 2014, 83(16): 1396-1402.

[1]	王靖萱, 吕迪阳, 方伯言. 帕金森病步态异常非药物康复循证研究：基于ClinicalTrials.gov数据库分析[J]. 《中国康复理论与实践》, 2023, 29(7): 816-821.
[2]	邓婷, 陈敬绵, 刘小蒙, 姚晓华, 刘芦姗, 何威, 张通, 芦海涛. 轻中度急性缺血性脑卒中并发卒中相关性肺炎的危险因素分析[J]. 《中国康复理论与实践》, 2023, 29(6): 708-713.
[3]	吴佳玉, 孟德涛, 梁潇潇. 体力活动水平对帕金森病发病风险的影响：基于CHARLS数据的横断面分析[J]. 《中国康复理论与实践》, 2023, 29(10): 1135-1139.
[4]	刘慧珍, 商娜, 李俊玉, 王娜, 李芳, 刘小蒙, 郭树彬. 血清25-羟维生素D与急诊病房卒中相关性肺炎发生及预后的相关性[J]. 《中国康复理论与实践》, 2023, 29(10): 1214-1220.
[5]	张春龙, 刘福亮, 商娜, 李芳, 刘慧珍. 血清脂联素、超敏C-反应蛋白与急性缺血性脑卒中短期预后的相关性[J]. 《中国康复理论与实践》, 2023, 29(10): 1221-1226.
[6]	石曼欣妤,孟德涛,方伯言. 帕金森病康复研究进展的可视化分析[J]. 《中国康复理论与实践》, 2022, 28(9): 1060-1064.
[7]	王洁萍,彭娟,张斐雪,樊必双,胥方元. 肢体协调训练对早期原发性帕金森病患者肺功能的效果[J]. 《中国康复理论与实践》, 2022, 28(8): 966-971.
[8]	谭茗丹,冯锭瑶,陈曦,刘汉军,李咏雪. 中文版构音障碍影响程度量表对帕金森病患者的信度和效度[J]. 《中国康复理论与实践》, 2022, 28(6): 696-703.
[9]	席晓明,毕鸿雁. 腹部扭转运动对帕金森病患者抑郁、便秘、运动症状和生活质量的效果[J]. 《中国康复理论与实践》, 2022, 28(2): 220-226.
[10]	刘阳,张孝权,王恒,齐莉萍. 虚拟现实技术对帕金森病患者综合平衡能力改善的Meta分析[J]. 《中国康复理论与实践》, 2021, 27(9): 1048-1058.
[11]	曹海豪,孙文玉,席晓明,王丽敏,毕鸿雁. 五禽戏对帕金森病患者平衡功能、步行能力及生活质量的效果[J]. 《中国康复理论与实践》, 2021, 27(9): 1087-1092.
[12]	肖琳娜,李晓红. 帕金森病冲动控制障碍的Scoping综述[J]. 《中国康复理论与实践》, 2021, 27(7): 774-779.
[13]	马惠姿,房进平,冯涛,蒋莹. 帕金森病患者不同程度抑郁在汉密尔顿抑郁量表的结构差异[J]. 《中国康复理论与实践》, 2021, 27(7): 829-833.
[14]	柳欣,尹志科,冯涛,邓永梅,赵越颖,董可,王春雪,马惠姿. 帕金森病并发淡漠的危险因素研究[J]. 《中国康复理论与实践》, 2021, 27(6): 719-723.
[15]	厉坤鹏,周宗磊,张梓楠,施伯翰,陈浩,罗云,朱燕. 呼吸训练对帕金森病患者肺功能和运动功能的效果[J]. 《中国康复理论与实践》, 2021, 27(3): 320-324.

帕金森病患者的血脂水平及其相关性

Relationship between Serum Lipid Levels and Parkinson's Disease

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0